|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$90,809.97 |
2.82% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$89,225.13 |
2.77% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$85,219.47 |
2.65% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$84,514.26 |
2.63% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$82,277.34 |
2.56% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,236.09 |
2.56% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$82,306.37 |
2.56% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$81,135.74 |
2.52% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$80,894.97 |
2.51% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$79,254.61 |
2.46% |
| Waters Corporation |
WAT |
941848103 |
184 |
$77,511.84 |
2.41% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,362.56 |
2.40% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,228.20 |
2.34% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$75,071.81 |
2.33% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$74,422.60 |
2.31% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$72,689.03 |
2.26% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$71,865.66 |
2.23% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$71,619.62 |
2.23% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$68,803.98 |
2.14% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$68,579.58 |
2.13% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,092.15 |
2.12% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$67,597.62 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$66,860.80 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$65,614.92 |
2.04% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$63,334.35 |
1.97% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$63,260.24 |
1.97% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,970.84 |
1.96% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$62,739.04 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,737.05 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$60,819.72 |
1.89% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$60,826.08 |
1.89% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,919.97 |
1.89% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,754.88 |
1.83% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$58,491.36 |
1.82% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,138.00 |
1.78% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,074.65 |
1.74% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$56,048.88 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$54,945.94 |
1.71% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$54,005.60 |
1.68% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$53,816.08 |
1.67% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$51,244.96 |
1.59% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$49,077.92 |
1.53% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$48,245.86 |
1.50% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,979.92 |
1.49% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$47,719.10 |
1.48% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,118.00 |
1.40% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$44,569.85 |
1.39% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$43,023.00 |
1.34% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$40,947.82 |
1.27% |
| US Dollar |
$USD |
|
13,864 |
$13,864.22 |
0.43% |
| Yuan Renminbi |
$CNY |
|
1,824 |
$271.47 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|